{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:33Z","timestamp":1761586953686,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601136"],"award-info":[{"award-number":["81601136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.intimp.2022.108804","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:08:37Z","timestamp":1651734517000},"page":"108804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash"],"prefix":"10.1016","volume":"109","author":[{"given":"Fuli","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuixia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2022.108804_b0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.anai.2019.08.004","article-title":"Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention","volume":"123","author":"Zhang","year":"2019","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.108804_b0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2022.108804_b0015","doi-asserted-by":"crossref","DOI":"10.1177\/1744806920901890","article-title":"Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments","volume":"16","author":"Gambeta","year":"2020","journal-title":"Mol Pain"},{"issue":"5","key":"10.1016\/j.intimp.2022.108804_b0020","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.intimp.2022.108804_b0025","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2217\/pgs.12.108","article-title":"HLA and pharmacogenetics of drug hypersensitivity","volume":"13","author":"Pavlos","year":"2012","journal-title":"Pharmacogenomics"},{"issue":"6982","key":"10.1016\/j.intimp.2022.108804_b0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2022.108804_b0035","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1528-1167.2010.02533.x","article-title":"Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population","volume":"51","author":"Tassaneeyakul","year":"2010","journal-title":"Epilepsia"},{"issue":"23","key":"10.1016\/j.intimp.2022.108804_b0040","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1212\/WNL.0000000000004008","article-title":"HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions","volume":"88","author":"Shi","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.intimp.2022.108804_b0045","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","article-title":"Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population","volume":"20","author":"Ozeki","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.intimp.2022.108804_b0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","article-title":"HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans","volume":"364","author":"McCormack","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.108804_b0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/504874","article-title":"Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study","volume":"43","author":"Rauch","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.intimp.2022.108804_b0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/clpt.2013.103","article-title":"Pirmohamed, and Consortium Clinical Pharmacogenetics Implementation, Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing","volume":"94","author":"Leckband","year":"2013","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2022.108804_b0065","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/cpt.1004","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update","volume":"103","author":"Phillips","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2022.108804_b0070","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1009717","article-title":"Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan","volume":"364","author":"Chen","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.intimp.2022.108804_b0075","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1517\/14656566.2010.495120","article-title":"Pharmacogenetics of toxic epidermal necrolysis","volume":"11","author":"Lee","year":"2010","journal-title":"Expert Opin. Pharmacother."},{"issue":"10","key":"10.1016\/j.intimp.2022.108804_b0080","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2217\/14622416.9.10.1543","article-title":"Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations","volume":"9","author":"Ferrell","year":"2008","journal-title":"Pharmacogenomics"},{"issue":"7404","key":"10.1016\/j.intimp.2022.108804_b0085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nature11147","article-title":"Immune self-reactivity triggered by drug-modified HLA-peptide repertoire","volume":"486","author":"Illing","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2022.108804_b0090","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3736\/jcim20110907","article-title":"Efficacy of Chinese patent medicine Tian Gui Capsule in patients with polycystic ovary syndrome: a randomized controlled trial","volume":"9","author":"Kuek","year":"2011","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"issue":"1","key":"10.1016\/j.intimp.2022.108804_b0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0092-8674(78)90296-9","article-title":"Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis","volume":"14","author":"Barnstable","year":"1978","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2022.108804_b0100","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1073\/pnas.94.12.6313","article-title":"Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis","volume":"94","author":"Zappacosta","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.intimp.2022.108804_b0105","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"D1","key":"10.1016\/j.intimp.2022.108804_b0110","doi-asserted-by":"crossref","first-page":"D1049","DOI":"10.1093\/nar\/gku1179","article-title":"Gene Ontology Consortium: going forward","volume":"43","author":"The Consortium Gene Ontology","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"10.1016\/j.intimp.2022.108804_b0115","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"suppl_2","key":"10.1016\/j.intimp.2022.108804_b0120","doi-asserted-by":"crossref","first-page":"W169","DOI":"10.1093\/nar\/gkm415","article-title":"DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists","volume":"35","author":"Huang","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.108804_b0125","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1074\/jbc.M114.607028","article-title":"Naturally processed non-canonical HLA-A*02:01 presented peptides","volume":"290","author":"Hassan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.108804_b0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.immuni.2018.12.011","article-title":"Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity","volume":"50","author":"Jayachandran","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2022.108804_b0135","doi-asserted-by":"crossref","first-page":"865","DOI":"10.3389\/fonc.2020.00865","article-title":"Ubiquitin C-Terminal Hydrolase L5 (UCHL5) Accelerates the Growth of Endometrial Cancer via Activating the Wnt\/beta-Catenin Signaling Pathway","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.intimp.2022.108804_b0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/bies.20235","article-title":"Coronin proteins as multifunctional regulators of the cytoskeleton and membrane trafficking","volume":"27","author":"Rybakin","year":"2005","journal-title":"BioEssays"},{"issue":"5788","key":"10.1016\/j.intimp.2022.108804_b0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.1130563","article-title":"Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis","volume":"313","author":"Foger","year":"2006","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.intimp.2022.108804_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1074\/mcp.M116.063800","article-title":"A Molecular Basis for the Presentation of Phosphorylated Peptides by HLA-B Antigens","volume":"16","author":"Alpizar","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"6","key":"10.1016\/j.intimp.2022.108804_b0155","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.108804_b0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/mcp.M116.066241","article-title":"The Human Leukocyte Antigen (HLA)-B27 Peptidome in Vivo, in Spondyloarthritis-susceptible HLA-B27 Transgenic Rats and the Effect of Erap1 Deletion","volume":"16","author":"Barnea","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.intimp.2022.108804_b0165","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/ncomms3039","article-title":"Exploring the MHC-peptide matrix of central tolerance in the human thymus","volume":"4","author":"Adamopoulou","year":"2013","journal-title":"Nat. Commun."},{"issue":"16","key":"10.1016\/j.intimp.2022.108804_b0170","doi-asserted-by":"crossref","first-page":"E1591","DOI":"10.1073\/pnas.1321902111","article-title":"The nature and extent of contributions by defective ribosome products to the HLA peptidome","volume":"111","author":"Bourdetsky","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.intimp.2022.108804_b0175","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M111.014050","article-title":"Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins","volume":"11","author":"Geiger","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"issue":"9","key":"10.1016\/j.intimp.2022.108804_b0180","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","article-title":"Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ","volume":"13","author":"Cox","year":"2014","journal-title":"Mol. Cell. Proteomics"},{"issue":"12","key":"10.1016\/j.intimp.2022.108804_b0185","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nchembio.1391","article-title":"A peptide\u2019s perspective on antigen presentation to the immune system","volume":"9","author":"Neefjes","year":"2013","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2022.108804_b0190","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1074\/mcp.M114.042812","article-title":"Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation","volume":"14","author":"Bassani-Sternberg","year":"2015","journal-title":"Mol. Cell. Proteomics"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:39:53Z","timestamp":1761586793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":38,"alternative-id":["S1567576922002880"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108804","relation":{},"ISSN":["1567-5769"],"issn-type":[{"type":"print","value":"1567-5769"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbamazepine-modified HLA-A*24:02-bound peptidome: Implication of CORO1A in skin rash","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.108804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108804"}}